Author

Natalie C. Silmon de Monerri

Pfizer (United States)ORCID 0000-0001-5480-6606Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:E. coli· 2 Approach:experimental assay· 2 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Assay:protein structure· 1 Assay:proteomics· 1

Frequent Co-Authors

Arthur Illenberger· 2 shared Christopher Ponce· 2 shared Jacqueline Lypowy· 2 shared Laurent Chorro· 2 shared Robert G. K. DonaldiD· 2 shared Alexandre Esadze· 1 shared Alexey V. GribenkoiD· 1 shared Annalena La Porte· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Arthur Illenberger

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologyFrontiers in ImmunologyPeer-reviewedJul 21, 2026

Improving the immunogenicity of E. coli FimH via multivalent display on I53-50 nanoparticles

Rebecca S Cole, Natalie C. Silmon de Monerri, Jacqueline Lypowy…·Neil P. King

This paper improves the immunogenicity of E. coli FimH by displaying it on I53-50 nanoparticles, achieving comparable antibody responses to higher doses of monomeric FimH with reduced adjuvant needs.

2 citations

E. coliproteomics

𝕏 PostBluesky

MicrobiologyPLoS PathogensPeer-reviewedFeb 19, 2025

Structure-Based Design of a Highly Immunogenic, Conformationally Stabilized FimH Antigen for a Urinary Tract Infection Vaccine

Natalie C. Silmon de Monerri, Ye Che, Joshua A. Lees…·Robert G. K. Donald

The paper designs a conformationally stabilized FimH antigen for a UTI vaccine, showing improved immunogenicity and structural similarity to native FimH.

20 citationstop 3%

E. coliprotein structure

𝕏 PostBluesky